ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	27/146	191/7206	5.52102395679e-16
ko05140	Leishmaniasis	16/146	75/7206	1.08334689993e-12
ko05321	Inflammatory bowel disease (IBD)	14/146	56/7206	2.93464423672e-12
ko04380	Osteoclast differentiation	19/146	134/7206	1.59845515348e-11
ko05152	Tuberculosis	22/146	187/7206	1.60502229197e-11
ko05145	Toxoplasmosis	17/146	126/7206	4.49600049323e-10
ko04650	Natural killer cell mediated cytotoxicity	15/146	97/7206	7.20572007097e-10
ko05150	Staphylococcus aureus infection	10/146	36/7206	1.38661668648e-09
ko04064	NF-kappa B signaling pathway	14/146	96/7206	6.04897747138e-09
ko05330	Allograft rejection	8/146	24/7206	1.31043774118e-08
ko05144	Malaria	10/146	45/7206	1.48912588189e-08
ko04217	Necroptosis	18/146	178/7206	1.5129561525e-08
ko04659	Th17 cell differentiation	14/146	106/7206	2.24664334119e-08
ko04630	Jak-STAT signaling pathway	15/146	132/7206	5.4706561428e-08
ko04660	T cell receptor signaling pathway	14/146	124/7206	1.69160612993e-07
ko05164	Influenza A	16/146	167/7206	2.1530446924e-07
ko05310	Asthma	6/146	17/7206	6.42761288282e-07
ko05162	Measles	13/146	120/7206	7.73763897097e-07
ko05340	Primary immunodeficiency	7/146	30/7206	1.67221568892e-06
ko04658	Th1 and Th2 cell differentiation	11/146	96/7206	3.26567111791e-06
ko05168	Herpes simplex infection	15/146	182/7206	3.58998178349e-06
ko04620	Toll-like receptor signaling pathway	11/146	100/7206	4.89331440361e-06
ko05133	Pertussis	10/146	87/7206	9.03021803754e-06
ko04662	B cell receptor signaling pathway	10/146	88/7206	1.00133839006e-05
ko04621	NOD-like receptor signaling pathway	13/146	157/7206	1.5765335463e-05
ko05320	Autoimmune thyroid disease	6/146	29/7206	2.01810686091e-05
ko05332	Graft-versus-host disease	5/146	18/7206	2.20819943138e-05
ko04664	Fc epsilon RI signaling pathway	9/146	77/7206	2.24552003864e-05
ko04666	Fc gamma R-mediated phagocytosis	11/146	122/7206	3.31164536061e-05
ko05142	Chagas disease (American trypanosomiasis)	11/146	130/7206	5.97118472211e-05
ko04672	Intestinal immune network for IgA production	6/146	37/7206	8.64191146048e-05
ko04145	Phagosome	12/146	162/7206	0.000100950215602
ko05167	Kaposi's sarcoma-associated herpesvirus infection	13/146	191/7206	0.000122542969513
ko05161	Hepatitis B	12/146	173/7206	0.000188546826038
ko04062	Chemokine signaling pathway	13/146	201/7206	0.000204261921171
ko04940	Type I diabetes mellitus	5/146	32/7206	0.000412925881599
ko05143	African trypanosomiasis	5/146	32/7206	0.000412925881599
ko05323	Rheumatoid arthritis	8/146	89/7206	0.000414228845386
ko04612	Antigen processing and presentation	7/146	77/7206	0.000892596275334
ko05169	Epstein-Barr virus infection	12/146	206/7206	0.000921680314194
ko04670	Leukocyte transendothelial migration	10/146	151/7206	0.000937629004065
ko04640	Hematopoietic cell lineage	6/146	64/7206	0.00177973642243
ko05132	Salmonella infection	7/146	98/7206	0.00361023820657
ko05146	Amoebiasis	7/146	99/7206	0.00382047548711
ko04514	Cell adhesion molecules (CAMs)	8/146	130/7206	0.00475336288212
ko05416	Viral myocarditis	5/146	55/7206	0.00491385831164
ko04610	Complement and coagulation cascades	6/146	79/7206	0.00515145525255
ko04611	Platelet activation	9/146	163/7206	0.00571108253537
ko04622	RIG-I-like receptor signaling pathway	5/146	62/7206	0.00816656845632
ko04144	Endocytosis	14/146	342/7206	0.0100102041556
ko05322	Systemic lupus erythematosus	8/146	151/7206	0.0114043923611
ko05160	Hepatitis C	8/146	153/7206	0.012282220171
ko05131	Shigellosis	5/146	82/7206	0.0250106521992
ko04917	Prolactin signaling pathway	5/146	87/7206	0.0312835290572
ko04668	TNF signaling pathway	6/146	120/7206	0.0346510524106
ko00660	C5-Branched dibasic acid metabolism	1/146	2/7206	0.0401140386719
ko04623	Cytosolic DNA-sensing pathway	3/146	41/7206	0.0496272941476